Search

Most people infected with SARS-CoV-2 have mild symptoms or none at all. However, a minority of people can develop severe symptoms, including difficulty breathing and pneumonia, and require…

Researchers at Sheffield Hallam University in Sheffield, England, recruited people for interviews who were experiencing long COVID. Using a database and an algorithm, researchers randomly selected a…

Although many people hospitalized with acute COVID-19 have died, many have also survived. After their recovery from acute COVID-19, some people have persistent symptoms. Researchers have recently…

Many people who developed serious complications of COVID-19 were hospitalized. Some of the people who survived have gone on to develop long-term complications (called long COVID).

In studies reviewed earlier in this issue of TreatmentUpdate, we examine data captured from as early as a few years after the introduction of potent HIV ...

As reported earlier in this issue of TreatmentUpdate, initiating HIV treatment (ART) is generally associated with an increase in weight. We now explore possible ...

As scientists move forward with studies of HIV-positive people and weight gain, it is important to take into account the presence of non-HIV drugs that have the ...

Crystal meth use has been linked to increased HIV and hepatitis C risk among gay and bi men. Researchers studied the effect of an anti-depressant on crystal ...

PrEP program models that can decentralize delivery and overcome barriers to access.

We speak to service providers from Saskatchewan, Quebec and British Columbia about programs that are making PrEP more accessible in their communities.

How is hepatitis C passed sexually and what strategies can be used to reduce the likelihood of sexual transmission?

This evidence review looks at integrating hepatitis C treatment into harm reduction programs and focuses on treatment outcomes, including adherence, cure and acceptability.